These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28194534)

  • 21. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.
    Tamblyn R; Huang A; Perreault R; Jacques A; Roy D; Hanley J; McLeod P; Laprise R
    CMAJ; 2003 Sep; 169(6):549-56. PubMed ID: 12975221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic substitutions: a 2005 survey of the acceptance and perceptions of physicians in Jamaica.
    Gossell-Williams M
    West Indian Med J; 2007 Oct; 56(5):458-63. PubMed ID: 18303760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the appropriateness of physician prescribing.
    Lexchin J
    Int J Health Serv; 1998; 28(2):253-67. PubMed ID: 9595343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physician drug dispensing in Switzerland: association on health care expenditures and utilization.
    Trottmann M; Frueh M; Telser H; Reich O
    BMC Health Serv Res; 2016 Jul; 16():238. PubMed ID: 27391118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in general practice prescribing costs and implications for budget setting.
    Healey AT; Yule BF; Reid JP
    Health Econ; 1994; 3(1):47-56. PubMed ID: 8167799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness.
    Jansson S; Anell A
    Health Policy; 2006 May; 76(3):299-311. PubMed ID: 16046026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The scale of repeat prescribing.
    Harris CM; Dajda R
    Br J Gen Pract; 1996 Nov; 46(412):649-53. PubMed ID: 8978110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality assurance for drug prescribing.
    Soumerai SB; McLaughlin TJ; Avorn J
    Qual Assur Health Care; 1990; 2(1):37-58. PubMed ID: 2103870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incentives for especially cost effective prescribing. The physician protects his budget, the patient saves co-pay].
    Schmidt K
    MMW Fortschr Med; 2006 Nov; 148(44):57, 59. PubMed ID: 17619443
    [No Abstract]   [Full Text] [Related]  

  • 32. The UK indicative prescribing scheme: background and operation.
    Bligh J; Walley T
    Pharmacoeconomics; 1992 Aug; 2(2):137-52. PubMed ID: 10146953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.
    Worthington HC; Cheng L; Majumdar SR; Morgan SG; Raymond CB; Soumerai SB; Law MR
    Implement Sci; 2017 Nov; 12(1):141. PubMed ID: 29178960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed budgets as a cost containment measure for pharmaceuticals.
    Granlund D; Rudholm N; Wikström M
    Eur J Health Econ; 2006 Mar; 7(1):37-45. PubMed ID: 16435117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Office of the Future Project: the integration of new technology into office practice. Academic detailing through the super highway. Quebec Research Group on Medication Use in the Elderly.
    Tamblyn RM; Jacques A; Laprise R; Huang A; Perreault R
    Clin Perform Qual Health Care; 1997; 5(2):104-8. PubMed ID: 10167210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do clinical grant payment practices in phase 3 clinical trials influence subsequent clinical investigator prescribing behavior?
    Glass HE
    Dis Manag; 2004; 7(1):77-87. PubMed ID: 15035835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: data from the pharmacotherapeutic quality circles in Hesse, Germany.
    Schubert ; Köster ; Ihle P; von Ferber L
    Int J Clin Pharmacol Ther; 2001 Nov; 39(11):492-8. PubMed ID: 11727970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The drug budget silo mentality: the Dutch case.
    Koopmanschap MA; Rutten FF
    Value Health; 2003; 6 Suppl 1():S46-51. PubMed ID: 12846925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introducing management principles into the supply and distribution of medicines in Tunisia.
    Garraoui A; Le Feuvre P; Ledoux M
    Bull World Health Organ; 1999; 77(6):525-9. PubMed ID: 10427939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.